“In-Silico Design of a Core Scaffold Pyrazolone Fused Heterocyclic Analogues As Dual Inhibitors Targeting Breast Cancer”. 2021. Asian Journal of Pharmaceutical and Health Sciences 11 (2): 2468-74. https://doi.org/10.5530/qsrddd17.